Progression To dementia in memory clinic patients without dementia: A latent profile analysis

Neurology

Volumn 81, Issue 15, 2013, Pages 1342-1349

  Köhler, Sebastian ^a   Hamel, Renske ^a   Sistermans, Nicole ^b   Koene, Ted ^c   Pijnenburg, Yolande A L ^b   Van Der Flier, Wiesje M ^b,d   Scheltens, Philip ^b   Visser, Pieter Jelle ^a,b   Aalten, Pauline ^a   Verhey, Frans R J ^a   Ramakers, Inez ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Neuroscience Campus Amsterdam ^*  (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; ATTENTION; COHORT ANALYSIS; CONTROLLED STUDY; DEMENTIA; DISEASE COURSE; EXECUTIVE FUNCTION; FEMALE; HIGH RISK PATIENT; HUMAN; INFORMATION PROCESSING; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MEMORY; MEMORY DISORDER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RECALL; RECOGNITION; RETROSPECTIVE STUDY; RISK ASSESSMENT; VERBAL MEMORY;

AGED; ATTENTION; COGNITION DISORDERS; COHORT STUDIES; DEMENTIA; DISEASE PROGRESSION; EXECUTIVE FUNCTION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY DISORDERS; MENTAL RECALL; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROPORTIONAL HAZARDS MODELS; PSYCHIATRIC STATUS RATING SCALES; RECOGNITION (PSYCHOLOGY); RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84888250281     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182a82536     Document Type: Article

References (37)

1. Gauthier S, Reisberg B, Zaudig M, et al. Mild cognitive impairment. Lancet 2006;367:1262-1270.
2. Visser PJ, Kester A, Jolles J, Verhey F. Ten-year risk of dementia in subjects with mild cognitive impairment. Neurology 2006;67:1201-1207.
3. Petersen RC, Morris JC. Mild cognitive impairment as a clinical entity and treatment target. Arch Neurol 2005;62:1160-1163.
4. Delano-Wood L, Bondi MW, Sacco J, et al. Heterogeneity in mild cognitive impairment: differences in neuropsychological profile and associated white matter lesion pathology. J Int Neuropsychol Soc 2009;15:906-914.
5. McKinlay A, Grace RC, Dalrymple-Alford JC, Roger D. Cognitive characteristics associated with mild cognitive impairment in Parkinson's disease. Dement Geriatr Cogn Disord 2009;28:121-129.
6. Libon DJ, Xie SX, Eppig J, et al. The heterogeneity of mild cognitive impairment: a neuropsychological analysis. J Int Neuropsychol Soc 2010;16:84-93.
7. Ylikoski R, Ylikoski A, Keskivaara P, Tilvis R, Sulkava R, Erkinjuntti T. Heterogeneity of cognitive profiles in aging: successful aging, normal aging, and individuals at risk for cognitive decline. Eur J Neurol 1999;6:645-652.
8. Hanfelt JJ, Wuu J, Sollinger AB, et al. An exploration of subgroups of mild cognitive impairment based on cognitive, neuropsychiatric and functional features: analysis of data from the National Alzheimer's Coordinating Center. Am J Geriatr Psychiatry 2011;19:940-950.
9. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968;114:797-811.
10. Gelinas I, Gauthier L, McIntyre M, Gauthier S. Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia. Am J Occup Ther 1999;53:471-481.
11. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004;256:183-194.
12. Lezak MD, Howieson DB, Loring DW. Neuropsychological Assessment, 4th ed. Oxford, UK: Oxford University Press; 2004.
13. van der Elst W, van Boxtel MP, van Breukelen GJ, Jolles J. Rey's Verbal Learning Test: normative data for 1855 healthy participants aged 24-81 years and the influence of age, sex, education, and mode of presentation. J Int Neuropsychol Soc 2005;11:290-302.
14. Schmand B, Houx P, de Koning I. Normen voor Stroop Kleur-Woord Tests, Trail Making Test en Story Recall van de Rivermead Behavioural Memory Test. Amsterdam: Nederlands Instituut van Psychologen, Sectie Neuropsychologie; 2003.
15. Hammes J. De Stroop Kleur-Woord Test: Handleiding [The Stroop Color-Word Test: Manual]. Amsterdam: Swets & Zeitlinger; 1973.
16. Van der Elst W, Van Boxtel M P J, Van Breukelen GJP, Jolles J. The Stroop Color-Word Test: influence of age, sex, and education; and normative data for a large sample across the adult age range. Assessment 2006;13:62-79.
17. Van der Elst W, Van Boxtel M P J, Van Breukelen G J P, Jolles J. Normative data for the Animal, Profession and Letter M Naming verbal fluency tests for Dutch speaking participants and the effects of age, education, and sex. J Int Neuropsychol Soc 2006;12:80-89.
18. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546-1554.
19. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260.
20. McKeith I, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005;65:1863-1872.
21. Garrett ES, Eaton WW, Zeger S. Methods for evaluating the performance of diagnostic tests in the absence of a gold standard: a latent class model approach. Stat Med 2002;21:1289-1307.
22. Nylund KL, Asparouhov T, Muthén BO. Deciding on the number of classes in latent class analysis and growth mixture modeling: a Monte Carlo simulation study. Struct Equation Model 2007;14:535-569.
23. Ramaswamy V, De Sarbo W, Reibstein D, Robinson W. An empirical pooling approach for estimating marketing mix elasticities with PIMS data. Marketing Sci 1993;12:103-124.
24. Thiébaut AC, Bénichou J. Choice of time-scale in Cox's model analysis of epidemiologic cohort data: a simulation study. Stat Med 2004;23:3803-3820.
25. Davidson JE, Irizarry MC, Bray BC, et al. An exploration of cognitive subgroups in Alzheimer's disease. J Int Neuropsychol Soc 2010;16:233-243.
26. Tabert MH, Manly JJ, Liu X, et al. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Arch Gen Psychiatry 2006;63:916-924.
27. Ewers M, Walsh C, Trojanowski JQ, et al. Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance. Neurobiol Aging 2012;33:1203-1214.
28. Gomar JJ, Bobes-Bascaran MT, Conejero-Goldberg C, Davies P, Goldberg TE; for the Alzheimer's Disease Neuroimaging Initiative. Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's Disease Neuroimaging Initiative. Arch Gen Psychiatry 2011;68:961-969.
29. Sacuiu S, Gustafson D, Johansson B, et al. The pattern of cognitive symptoms predicts time to dementia onset. Alzheimers Dement 2009;5:199-206.
30. O'Brien JT, Erkinjuntti T, Reisberg B, et al. Vascular cognitive impairment. Lancet Neurol 2003;2:89-98.
31. Price CC, Jefferson AL, Merino JG, Heilman KM, Libon DJ. Subcortical vascular dementia: integrating neuropsychological and neuroradiologic data. Neurology 2005;65:376-382.
32. Visser PJ, Verhey FR, Hofman PA, Scheltens P, Jolles J. Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment. J Neurol Neurosurg Psychiatry 2002;72:491-497.
33. De Toledo-Morrell L, Stoub TR, Bulgakova M, et al. MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD. Neurobiol Aging 2004;25:1197-1203.
34. Dos Santos V, Thomann PA, Wüstenberg T, Seidl U, Essig M, Schröder J. Morphological cerebral correlates of CERAD test performance in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis 2011;23:411-420.
35. Kerchner GA, Deutsch GK, Zeineh M, Dougherty RF, Saranathan M, Rutt BK. Hippocampal CA1 apical neuropil atrophy and memory performance in Alzheimer's disease. Neuroimage 2012;63:194-202.
36. Seelaar H, Rohrer JD, Pijnenburg Y A L, Fox NC, van Swieten JC. Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review. J Neurol Neurosurg Psychiatry 2011;82:476-486.
37. Steffens DC, Otey E, Alexopoulos GS, et al. Perspectives on depression, mild cognitive impairment, and cognitive decline. Arch Gen Psychiatry 2006;63:130-138.